PROBLEM TO BE SOLVED: To provide agents for the treatment of a condition mediated by 5-HT4 receptor activity such as gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, nonulcer dyspepsia, functional dyspepsia, irritable bowel syndrome (IBS), constipation, dyspepsia, esophagitis, gastroesophageal disease, nausea, central nervous system disease, Alzheimers disease, cognitive disorder, emesis, migraine, neurological disease, pain, cardiovascular disorders such as cardiac failure and heart arrhythmia, diabetes and apnea syndrome.SOLUTION: This invention relates to compounds of formula (I).COPYRIGHT: (C)2012,JPO&INPIT【課題】胃食道逆流症、消化器疾患、胃の運動性障害、非潰瘍性消化不良、機能性消化不良、過敏性大腸症候群(IBS)、便秘、消化不良、食道炎、胃食道疾患、悪心、中枢神経系疾患、アルツハイマー病、認知障害、催吐、偏頭痛、神経疾患、疼痛、心不全や心臓不整脈などの心臓血管障害、糖尿病、無呼吸症候群などの5-HT4受容体活性によって媒介される状態の治療薬の提供。【解決手段】下記式(I)で表される化合物。【選択図】なし
